Skip to main content
. 2021 May 7;100(18):e25690. doi: 10.1097/MD.0000000000025690

Table 2.

The baseline characteristics of the participants.

Characteristics Treatment group Control group P value
Case, N 36 32
Mean age (years ± SD) 55.64 ± 9.84 58.50 ± 9.41 .226
Range 36-72 39-78
Sex .737
 Male 25 21
 Female 11 11
Metastatic sites .979
 Pulmonary metastases 11 11
 Liver metastases 6 4
 Brain metastases 6 5
 Bone metastases 8 6
 Adrenal metastases 2 1
 Lymphatic metastases 24 23
 Others 8 10
TNM Stage .153
 IIIA 1 5
 IIIB 7 4
 IV 28 23
Histological type .365
 Squamous cell carcinoma 12 6
 Adenocarcinoma 21 24
 adenosquamous carcinoma 1 0
 Large cell carcinoma 0 1
 Other 2 1
Ongoing Chemotherapy .672
 First-line 23 22
 Second-line 13 10
ECOG PS .409
 0 1 0
 1 25 26
 2 10 6
TCM Syndromes .136
 Disharmony of spleen and stomach 5 3
 Deficiency of qi and blood 10 7
 Yin deficiency of liver and kidney 21 22

ECOG = Eastern Cooperative Oncology Group.

t test or χ2 test.

Based on TNM Classification, the 7th edition.